Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark Levine Insider Profile
4 Followers
Mark Levine, SVP,General Counsel & Sec. at Minerva Neurosciences, holds 347.12K shares in Immunovant (Ticker: IMVT), holds 0.00 shares in Flexion Therapeutics (Ticker: FLXN), holds 0.00 shares in Minerva Neurosciences (Ticker: NERV). Most recently, Mark Levine Sold ― shares of Immunovant on Apr 19, 2024 for an estimated value of 285.55K.
Mark Levine Minerva Neurosciences (NERV)SVP,General Counsel & Sec.
Minerva Neurosciences (NERV)
SVP,General Counsel & Sec.
Ranked #84,023 out of 98,564 Corporate Insiders
Profitable Transactions
4 out of 9 Profitable Transactions
Average Return
-19.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mark Levine holds in companies
Most Profitable Insider Trade
The most profitable trade made by Mark Levine
Mark Levine's Trading History
Minerva Neurosciences
Jun 05, 2017
SVP,General Counsel & Sec.
Uninformative Sell
192.50K
$0.00
Flexion Therapeutics
Nov 19, 2021
―
Uninformative Sell
1.13M
$0.00
Immunovant
Apr 19, 2024
CLO
Informative Sell
285.55K
$9.93M
List of latest transactions for each holding click on a transaction to see Mark Levine's performance on stock
You May Also Like
Mark Levine insider profile FAQ
What is the percentage of profitable transactions made by Mark Levine?
The percentage of profitable transactions made by Mark Levine is 44%.
What is the average return per transaction made by Mark Levine?
The average return per transaction made by Mark Levine is -19.80%.
What stocks does Mark Levine hold?
Mark Levine holds: NERV, FLXN, IMVT stocks.
What was Mark Levine’s latest transaction?
Mark Levine latest transaction was an Informative Sell of $285.55K.
What was Mark Levine's most profitable transaction?
Mark Levine’s most profitable transaction was an Informative Sell of IMVT stock on January 29, 2024. The return on the trade was 28.20%.
What is Mark Levine's role in Minerva Neurosciences?
Mark Levine's role in Minerva Neurosciences is SVP,General Counsel & Sec..
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.